Iniciar sesión Regístrese gratis

co.don AG Capitalización de mercado

¿Qué es el Capitalización de mercado de co.don AG?

El Capitalización de mercado de co.don AG es $62.78M

¿Cuál es la definición de Capitalización de mercado ?



La capitalización de mercado es el valor de mercado en un momento en el tiempo de las acciones en circulación de una empresa que cotiza en bolsa, que es igual al precio de la acción en ese punto de tiempo por el número de acciones en circulación .

As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.

Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.

The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.

Capitalización de mercado de compañías en Sector Health Care en XETRA en comparadas con co.don AG

¿Qué hace co.don AG?

co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide. The company develops, produces, and markets autologous cell therapies for the minimally invasive repair of cartilage damage to knee joints following traumatic or degenerative defects. Its therapies include matrix-associated autologous cartilage transplantation, a biological therapy for the treatment of damaged articular cartilage with the body's own cells; and autologous chondrocyte transplantation for the regeneration of biomechanical load-bearing and pressure-resistant cartilage tissue. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.

Empresas con capitalización de mercado similar a co.don AG